scholarly journals Fetal Remains Post-Spontaneous Abortion: Ethical Consideration

2021 ◽  
Vol 10 (4) ◽  
pp. 83-85
Author(s):  
Seyed Mohammad Nahidi ◽  
Farah Awad ◽  
Drezelle Mills ◽  
Victoria Lewis ◽  
Patrisha Woolard
Keyword(s):  
Spontaneous Abortion ◽  
Ethical Consideration

Spontaneous abortion, PTSD, and support

2008 ◽  
Author(s):  
Stephen V. Bowles ◽  
Cheryl Koopman ◽  
Ted Epperly ◽  
Lynn Breckenridge ◽  
Tiffany Nayduch
Keyword(s):  
Spontaneous Abortion

Erhöhtes Abortrisiko bei Antibiotikatherapie in der Schwangerschaft

2017 ◽  
Vol 221 (04) ◽  
pp. 155-155
Keyword(s):  
Spontaneous Abortion

Muanda FT et al. Use of antibiotics during pregnancy and risk of spontaneous abortion. CMAJ 2017; 189: E625–633 Muss bei der Einnahme von Antibiotika während der Schwangerschaft mit einem erhöhten Risiko für Fehlgeburten gerechnet werden? Diese Frage wird in der Literatur kontrovers diskutiert. Eine aktuelle kanadische Studie belegt: einige Wirkstoffe können den Verlauf der Frühschwangerschaft ungünstig beeinflussen.

Association between Thiopurines Use and Pregnancy Outcomes in Female Patients with Inflammatory Bowel Disease: A Meta-analysis

2020 ◽  
Vol 26 ◽  
Author(s):  
Yang Zhang ◽  
Dandan Li ◽  
Heng Guo ◽  
Weina Wang ◽  
Xingang Li ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Preterm Birth ◽  
Spontaneous Abortion ◽  
Bowel Disease ◽  
Pregnancy Outcomes ◽  
Congenital Malformations ◽  
Meta Analysis ◽  
Adverse Pregnancy Outcomes ◽  
Inflammatory Bowel ◽  
Adverse Pregnancy

Background: Conflicting data exist regarding the influence of thiopurines exposure on adverse pregnancy outcomes in female patients with inflammatory bowel disease (IBD). Objective: The aim of this study was to provide an up-to-date and comprehensive assessment of the safety of thiopurines in pregnant IBD women. Methods: All relevant articles reporting pregnancy outcomes in women with IBD received thiopurines during pregnancy were identified from the databases (PubMed, Embase, Cochrane Library, and ClinicalTrials.gov) with the publication data up to April 2020. Data of included studies were extracted to calculate the relative risk (RR) of multiple pregnancy outcomes: congenital malformations, low birth weight (LBW), preterm birth, small for gestational age (SGA), and spontaneous abortion. The meta-analysis was performed using the random-effects model. Results: Eight studies matched with the inclusion criteria and a total of 1201 pregnant IBD women who used thiopurines and 4189 controls comprised of women with IBD received drugs other than thiopurines during pregnancy were included. Statistical analysis results demonstrated that the risk of preterm birth was significantly increased in the thiopurine-exposed group when compared to IBD controls (RR, 1.34; 95% CI, 1.00-1.79; p=0.049; I 2 =41%), while no statistically significant difference was observed in the incidence of other adverse pregnancy outcomes. Conclusion: Thiopurines’ use in women with IBD during pregnancy is not associated with congenital malformations, LBW, SGA, or spontaneous abortion, but appears to have an association with an increased risk of preterm birth.

Sign in / Sign up

Export Citation Format

Share Document